Dorantes-Heredia Rita, Motola-Kuba Daniel, Escamilla-López Ixel, Téllez-Bernal Eduardo, Conde-Flores Emilio, Escalera-Santamaría Daniel, Medina-Ceballos Emilio, Ruiz-Morales José, Dorokhova Elena, Flores-García Lucia Edith, Lugo Gabriela, Filio-Rodríguez Georgina Del C
Departamento de Anatomía Patológica, Médica Sur, Mexico City 14050, Mexico.
Centro Oncológico, Médica Sur, Mexico City 14050, Mexico.
J Pers Med. 2024 Dec 13;14(12):1152. doi: 10.3390/jpm14121152.
: Mismatch repair (MMR) status is an important prognostic and predictive indicator in cancer, distinguishing proficient (pMMR) tumors from deficient (dMMR) ones. This study aimed to determine the prevalence of dMMR in colorectal (CRC) and selected non-CRC solid tumors (gastric, esophageal, and endometrial cancers). : This retrospective study was conducted at a private health institution in Mexico City, analyzing patients diagnosed with colorectal, gastric, esophageal, or endometrial cancer from January 2017 to December 2020. dMMR prevalence was assessed using available status information and tissue samples for immunohistochemistry (IHC). Data were analyzed via SPSS, presenting results in frequencies and percentages. : Most solid tumors exhibited MSH2, MSH6, and MLH1 expression above 90%, with slightly lower levels in endometrial cancer. Esophageal cancer showed 100% pMMR. dMMR prevalence was found to be 12.7% for CRC, 8.3% for gastric, and 18.5% for endometrial cancers. Prevalence rates were similar across genders (11.1% in women and 12.9% in men), with the highest prevalence in the 41-50 age group (20%) and the lowest in the 31-40 age group (7.7%). : This study offers valuable insights into the frequency of dMMR mutations in a cohort of the Mexican population, providing a basis for further research on their prevalence in Mexico.
错配修复(MMR)状态是癌症中一项重要的预后和预测指标,可区分错配修复功能完整(pMMR)肿瘤和错配修复功能缺陷(dMMR)肿瘤。本研究旨在确定结直肠癌(CRC)以及选定的非结直肠癌实体瘤(胃癌、食管癌和子宫内膜癌)中dMMR的发生率。:本回顾性研究在墨西哥城的一家私立医疗机构开展,分析了2017年1月至2020年12月期间被诊断为结直肠癌、胃癌、食管癌或子宫内膜癌的患者。使用现有的状态信息和组织样本进行免疫组织化学(IHC)检测来评估dMMR的发生率。通过SPSS对数据进行分析,结果以频率和百分比呈现。:大多数实体瘤中MSH2、MSH6和MLH1的表达率高于90%,子宫内膜癌中的表达水平略低。食管癌的错配修复功能完整率为100%。结直肠癌的dMMR发生率为12.7%,胃癌为8.3%,子宫内膜癌为18.5%。不同性别的发生率相似(女性为11.1%,男性为12.9%),41 - 50岁年龄组的发生率最高(20%),31 - 40岁年龄组的发生率最低(7.7%)。:本研究为墨西哥人群队列中dMMR突变的频率提供了有价值的见解,为进一步研究其在墨西哥的患病率提供了依据。